Literature DB >> 26545850

Is Ureteroscopy Needed Prior to Nephroureterectomy? An Evidence-Based Algorithmic Approach.

Aaron M Potretzke1, B Alexander Knight1, Theodora A Potretzke2, Jeffrey A Larson1, Sam B Bhayani3.   

Abstract

OBJECTIVE: To develop an evidence-based approach to the diagnostic workup of suspicious upper urinary tract lesions.
METHODS: The PubMed database was searched using the following terms with a filter for English language: "upper tract urothelial carcinoma" and "upper tract transitional cell carcinoma," along with the following corresponding terms: "cost," "epidemiology," "diagnosis," "ureteroscopy," and "workup." A total of 404 articles were returned, and 33 were reviewed in full based on relevance.
RESULTS: Computed tomography urogram is both sensitive and specific (96% and 99%). Cytology is utilized for its specificity (89%-100%). Ureteroscopy and biopsy of an upper tract lesion can be helpful in equivocal cases but can pose challenges in terms of yield and eventual pathologic upstaging. Due to the high sensitivity and specificity of other noninvasive tests, ureteroscopy can be obviated in select cases. We assess the available evidence and devise an algorithm for the evaluation of an upper tract urothelial carcinoma lesion.
CONCLUSION: Ureteroscopy can be omitted as part of the diagnostic workup in appropriately selected cases of upper tract urothelial carcinoma.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26545850     DOI: 10.1016/j.urology.2015.08.046

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  7 in total

1.  Clinical Outcomes in Patients with Panurothelial Carcinoma Treated with Radical Nephroureterectomy Following Cystectomy for Metachronous Recurrence.

Authors:  Qiang Li; Melissa Assel; Nicole Benfante; Eugene Pietzak; Aditya Bagrodia; Eugene Cha; Guido Dalbagni; Jonathan Coleman
Journal:  J Urol       Date:  2017-03-22       Impact factor: 7.450

2.  Long-term outcomes of upper tract urothelial carcinoma: A retrospective evaluation of single-center experience in 275 patients.

Authors:  Mohamed Mohamed Elawdy; Yasser Osman; Diaa Eldin Taha; Samer El-Halwagy; Mohamed Abd El-Hamid; Rasha T Abouelkheir
Journal:  Turk J Urol       Date:  2019-02-05

Review 3.  Update of the ICUD-SIU consultation on upper tract urothelial carcinoma 2016: treatment of low-risk upper tract urothelial carcinoma.

Authors:  Rao S Mandalapu; Mesut Remzi; Theo M de Reijke; Vitaly Margulis; J Palou; A Kapoor; Ofer Yossepowitch; Jonathan Coleman; Olivier Traxer; J Kyle Anderson; James Catto; Jean de la Rosette; Timothy O'Brien; Anthony Zlotta; Surena F Matin
Journal:  World J Urol       Date:  2016-05-27       Impact factor: 4.226

Review 4.  Endoscopic Treatment of Upper Tract Urothelial Carcinoma.

Authors:  Daniel P Verges; Costas D Lallas; Scott G Hubosky; Demetrius H Bagley
Journal:  Curr Urol Rep       Date:  2017-04       Impact factor: 3.092

Review 5.  Ureteroscopic biopsy of upper tract urothelial carcinoma and role of urinary biomarkers.

Authors:  Katherine E Smentkowski; Demetrius H Bagley; Scott G Hubosky
Journal:  Transl Androl Urol       Date:  2020-08

6.  The accuracy of computed tomography in the diagnosis of upper urinary tract urothelial carcinoma in correlation with the final histopathology: A retrospective study in 275 patients at a Tertiary Urology Institute.

Authors:  Rasha T Abouelkheir; Mohamed Mohamed Elawdy; Diaa Eldin Taha; Mohamed Abd El-Hamid; Yasser Osman; Tarek El-Diasty
Journal:  Urol Ann       Date:  2021-09-02

7.  Adjuvant chemotherapy improves survival of patients with high-risk upper urinary tract urothelial carcinoma: a propensity score-matched analysis.

Authors:  Kazutoshi Fujita; Kei Taneishi; Teruo Inamoto; Yu Ishizuya; Shingo Takada; Masao Tsujihata; Go Tanigawa; Noriko Minato; Shigeaki Nakazawa; Tsuyoshi Takada; Toshichika Iwanishi; Motohide Uemura; Yasushi Okuno; Haruhito Azuma; Nonomura Norio
Journal:  BMC Urol       Date:  2017-12-01       Impact factor: 2.264

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.